Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHRONIC LYMPHOCYTIC B-LEUKEMIA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00749502
What this trial is testing

MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)

Who this might be right for
Solid TumorsChronic Lymphocytic LeukemiaT-cell-prolymphocytic Leukemia
Tesaro, Inc. 113
Testing effectiveness (Phase 2)Study completedNCT02581007
What this trial is testing

Reduced Intensity Conditioning Transplant Using Haploidentical Donors

Who this might be right for
Chronic Myelogenous LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndrome+7 more
Northside Hospital, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT00077922
What this trial is testing

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphocyticChronic
National Cancer Institute (NCI) 15
Not applicableEnded earlyNCT00176930
What this trial is testing

Stem Cell Transplant for Hematological Malignancy

Who this might be right for
Leukemia, Myeloid, ChronicAMLLeukemia, Lymphocytic, Acute+6 more
Masonic Cancer Center, University of Minnesota 330
Early research (Phase 1)Study completedNCT00012207
What this trial is testing

Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Fred Hutchinson Cancer Center 12
Post-approval studies (Phase 4)Study completedNCT01255644
What this trial is testing

Antiviral Treatment of Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Medical University of Vienna 20
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Testing effectiveness (Phase 2)Ended earlyNCT02991898
What this trial is testing

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT00072514
What this trial is testing

Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+28 more
Fred Hutchinson Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT01369849
What this trial is testing

Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Ended earlyNCT00038415
What this trial is testing

A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach

Who this might be right for
Leukemia, Lymphocytic, Chronic
M.D. Anderson Cancer Center 2
Not applicableStudy completedNCT03870633
What this trial is testing

Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma

Who this might be right for
Chronic Lymphocytic LeukemiaPlasma Cell Myeloma
Alliance for Clinical Trials in Oncology 521
Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Not applicableUnknownNCT00336206
What this trial is testing

Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Tawam Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07819214
What this trial is testing

Epcoritamab as Consolidation Therapy for High-Risk Pts w/CLL on BTKI

Who this might be right for
CLLCLL (Chronic Lymphocytic Leukemia)Chronic Lymphocytic Leukemia (CLL)+1 more
University of California, Irvine 24
Early research (Phase 1)Study completedNCT02006485
What this trial is testing

Ublituximab in Combination With TGR-1202 +/- Ibrutinib or Bendamustine in Patients With B-cell Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin's Lymphoma
TG Therapeutics, Inc. 160
Testing effectiveness (Phase 2)Looking for participantsNCT06564038
What this trial is testing

AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Who this might be right for
Chronic Lymphocytic LeukaemiaSmall Lymphocytic LymphomaMantle-cell Lymphoma+2 more
AstraZeneca 408
Large-scale testing (Phase 3)UnknownNCT01657955
What this trial is testing

Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaLeukemiaNeoplasms
Shandong Lanjin Pharmaceuticals Co.,Ltd 96
Testing effectiveness (Phase 2)Study completedNCT00295932
What this trial is testing

Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 79
Early research (Phase 1)Study completedNCT00642031
What this trial is testing

Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesLeukemia
Prescient Therapeutics, Ltd. 20
Next Page